The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Fox, Gabriel Max, Dr
    Medical Doctor born in February 1966
    Individual (5 offsprings)
    Officer
    2022-06-15 ~ now
    OF - Director → CIF 0
    Dr Gabriel Max Fox
    Born in February 1966
    Individual (5 offsprings)
    Person with significant control
    2022-06-15 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Walker, Joanna Louise
    Clinical Researcher born in August 1972
    Individual (2 offsprings)
    Officer
    2022-06-15 ~ now
    OF - Director → CIF 0
    Mrs Joanna Louise Walker
    Born in August 1972
    Individual (2 offsprings)
    Person with significant control
    2022-06-15 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

AMICUS CLINICAL DEVELOPMENT LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Average Number of Employees
22023-05-01 ~ 2024-04-30
22022-06-15 ~ 2023-04-30
Debtors
Current
63,806 GBP2024-04-30
81,702 GBP2023-04-30
Cash at bank and in hand
173,894 GBP2024-04-30
127,833 GBP2023-04-30
Current Assets
237,700 GBP2024-04-30
209,535 GBP2023-04-30
Creditors
Current, Amounts falling due within one year
-89,767 GBP2024-04-30
-68,588 GBP2023-04-30
Net Current Assets/Liabilities
147,933 GBP2024-04-30
140,947 GBP2023-04-30
Total Assets Less Current Liabilities
147,933 GBP2024-04-30
140,947 GBP2023-04-30
Net Assets/Liabilities
147,933 GBP2024-04-30
140,947 GBP2023-04-30
Equity
Called up share capital
1,000 GBP2024-04-30
1,000 GBP2023-04-30
Retained earnings (accumulated losses)
146,933 GBP2024-04-30
139,947 GBP2023-04-30
Equity
147,933 GBP2024-04-30
140,947 GBP2023-04-30
Trade Debtors/Trade Receivables
Current
63,296 GBP2024-04-30
81,163 GBP2023-04-30
Prepayments/Accrued Income
Current
510 GBP2024-04-30
539 GBP2023-04-30
Trade Creditors/Trade Payables
Current
22,403 GBP2024-04-30
6,562 GBP2023-04-30
Corporation Tax Payable
Current
45,563 GBP2024-04-30
52,940 GBP2023-04-30
Taxation/Social Security Payable
Current
19,211 GBP2024-04-30
6,686 GBP2023-04-30
Accrued Liabilities/Deferred Income
Current
2,590 GBP2024-04-30
2,400 GBP2023-04-30
Creditors
Current
89,767 GBP2024-04-30
68,588 GBP2023-04-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
250 shares2024-04-30
250 shares2023-04-30
Par Value of Share
Class 1 ordinary share
1.002023-05-01 ~ 2024-04-30
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
250 shares2024-04-30
250 shares2023-04-30
Par Value of Share
Class 2 ordinary share
1.002023-05-01 ~ 2024-04-30
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
250 shares2024-04-30
250 shares2023-04-30
Par Value of Share
Class 3 ordinary share
1.002023-05-01 ~ 2024-04-30
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
250 shares2024-04-30
250 shares2023-04-30
Par Value of Share
Class 4 ordinary share
1.002023-05-01 ~ 2024-04-30

  • AMICUS CLINICAL DEVELOPMENT LIMITED
    Info
    Registered number 14173564
    177 Huntingdon Road, Cambridge CB3 0DH
    Private Limited Company incorporated on 2022-06-15 (3 years). The company status is Active.
    The last date of confirmation statement was made at 2024-06-14
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.